Literature DB >> 12690143

Absence of hepatitis C virus transmission in a prospective cohort of heterosexual serodiscordant couples.

B Marincovich1, J Castilla, J del Romero, S García, V Hernando, M Raposo, C Rodríguez.   

Abstract

OBJECTIVE: To analyse hepatitis C virus (HCV) transmission in a cohort of heterosexual couples who are discordant both for HIV and for HCV.
METHODS: We followed an open cohort of 171 people, 152 women and 19 men, who were not initially infected by either HIV or HCV, and whose steady heterosexual partner presented antibodies to both viruses (index case). Other risk exposures were excluded. Every 6 months clinical, epidemiological, and risk behaviour information was collected, and antibodies to both viruses were determined.
RESULTS: During 529 person years of follow up more than 40 000 vaginal or anal penetrations were recorded. 74 partners (43.3%) had vaginal and/or anal intercourse without condoms with the index case; another 15.8%, who always used condoms, declared breaking or slipping episodes during intercourse; and another 22.2% had unprotected orogenital exposures. During the follow up, over 5800 unprotected vaginal and anal contacts with the index case were estimated, as well as more than 25 000 unprotected orogenital contacts. 31 women became pregnant (two were index cases), and seroconversion to HIV occurred for one woman (1.7 per 10 000 unprotected contacts; 95% CI, 0 to 9.5), but there was no seroconversion to HCV (95% CI, 0-6.3 per 10 000 unprotected contacts).
CONCLUSION: These results are consistent with a low or null transmissibility of HCV in heterosexual relations, even when the index case is HIV co-infected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12690143      PMCID: PMC1744643          DOI: 10.1136/sti.79.2.160

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  27 in total

Review 1.  Updating the management of sexually transmitted infections.

Authors:  Catriona Ooi; David Lewis
Journal:  Aust Prescr       Date:  2015-12-01

Review 2.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Authors:  Susanna Naggie; Mark S Sulkowski
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

Review 3.  Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.

Authors:  Yaron Rotman; T Jake Liang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

4.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

Review 5.  Estimating per-act HIV transmission risk: a systematic review.

Authors:  Pragna Patel; Craig B Borkowf; John T Brooks; Arielle Lasry; Amy Lansky; Jonathan Mermin
Journal:  AIDS       Date:  2014-06-19       Impact factor: 4.177

6.  Sexual transmission of hepatitis C: A rare event among heterosexual couples.

Authors:  Jennifer L Dodge; Norah A Terrault
Journal:  J Coagul Disord       Date:  2014-03

7.  Risky sexual behavior, bleeding caused by intimate partner violence, and hepatitis C virus infection in patients of a sexually transmitted disease clinic.

Authors:  Marcia Russell; Meng-Jinn Chen; Thomas H Nochajski; Maria Testa; Scott J Zimmerman; Patricia S Hughes
Journal:  Am J Public Health       Date:  2009-02-12       Impact factor: 9.308

8.  Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individuals.

Authors:  E Orsetti; S Staffolani; R Gesuita; G De Iaco; E Marchionni; L Brescini; P Castelli; F Barchiesi
Journal:  Infection       Date:  2013-05-24       Impact factor: 3.553

Review 9.  Best strategies for global HCV eradication.

Authors:  Liesl M Hagan; Raymond F Schinazi
Journal:  Liver Int       Date:  2013-02       Impact factor: 5.828

10.  Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.

Authors:  C H S B van den Berg; T J W van de Laar; A Kok; F R Zuure; R A Coutinho; M Prins
Journal:  J Viral Hepat       Date:  2009-02-23       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.